NRX Pharmaceuticals (NASDAQ: NRXP) is frequently classified within the broader category of micro-cap or small-cap biotech equities because its share price often fluctuates around or below the five-dollar threshold. Consequently, it exhibits the heightened price swings, lower liquidity profiles, and speculative trading characteristics typically associated with low-priced pharmaceutical equities.